PortfoliosLab logoPortfoliosLab logo
BIGT.L vs. HEAE.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BIGT.L vs. HEAE.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in L&G Pharma Breakthrough UCITS ETF (BIGT.L) and SPDR MSCI Europe Health Care UCITS ETF (HEAE.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

BIGT.L is traded in GBp, while HEAE.L is traded in GBP. To make them comparable, the HEAE.L values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, BIGT.L achieves a -0.70% return, which is significantly higher than HEAE.L's -2.42% return.


BIGT.L

1D
2.65%
1M
-4.10%
YTD
-0.70%
6M
-3.42%
1Y
26.08%
3Y*
2.96%
5Y*
2.49%
10Y*

HEAE.L

1D
3.29%
1M
1.82%
YTD
-2.42%
6M
-1.32%
1Y
9.06%
3Y*
2.88%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

BIGT.L vs. HEAE.L - Yearly Performance Comparison


2026 (YTD)2025202420232022
BIGT.L
L&G Pharma Breakthrough UCITS ETF
-0.70%27.03%-3.16%-14.88%0.72%
HEAE.L
SPDR MSCI Europe Health Care UCITS ETF
-2.42%13.38%-1.21%5.53%-5.60%

Correlation

The correlation between BIGT.L and HEAE.L is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.60

Correlation (3Y)
Calculated over the trailing 3-year period

0.50

Correlation (All Time)
Calculated using the full available price history since Apr 11, 2022

0.46

The correlation between BIGT.L and HEAE.L shifts across timeframes, from 0.46 (all time) to 0.60 (1 year), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BIGT.L vs. HEAE.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIGT.L
BIGT.L Risk / Return Rank: 4343
Overall Rank
BIGT.L Sharpe Ratio Rank: 4040
Sharpe Ratio Rank
BIGT.L Sortino Ratio Rank: 4141
Sortino Ratio Rank
BIGT.L Omega Ratio Rank: 3737
Omega Ratio Rank
BIGT.L Calmar Ratio Rank: 5353
Calmar Ratio Rank
BIGT.L Martin Ratio Rank: 4545
Martin Ratio Rank

HEAE.L
HEAE.L Risk / Return Rank: 1818
Overall Rank
HEAE.L Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
HEAE.L Sortino Ratio Rank: 1818
Sortino Ratio Rank
HEAE.L Omega Ratio Rank: 1818
Omega Ratio Rank
HEAE.L Calmar Ratio Rank: 1717
Calmar Ratio Rank
HEAE.L Martin Ratio Rank: 1717
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIGT.L vs. HEAE.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for L&G Pharma Breakthrough UCITS ETF (BIGT.L) and SPDR MSCI Europe Health Care UCITS ETF (HEAE.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BIGT.LHEAE.LDifference
Sharpe ratioReturn per unit of total volatility

+0.85

Sortino ratioReturn per unit of downside risk

+1.14

Omega ratioGain probability vs. loss probability

1.24

1.11

+0.13

Calmar ratioReturn relative to maximum drawdown

2.57

0.66

+1.91

Martin ratioReturn relative to average drawdown

7.42

1.57

+5.85

BIGT.L vs. HEAE.L - Sharpe Ratio Comparison

The current BIGT.L Sharpe Ratio is 1.39, which is higher than the HEAE.L Sharpe Ratio of 0.54. The chart below compares the historical Sharpe Ratios of BIGT.L and HEAE.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BIGT.LHEAE.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.39

0.54

+0.85

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.15

Sharpe Ratio (All Time)

Calculated using the full available price history

0.22

0.14

+0.07

Drawdowns

BIGT.L vs. HEAE.L - Drawdown Comparison

The maximum BIGT.L drawdown since its inception was -30.23%, which is greater than HEAE.L's maximum drawdown of -24.51%. Use the drawdown chart below to compare losses from any high point for BIGT.L and HEAE.L.


Loading charts...

Drawdown Indicators


BIGT.LHEAE.LDifference

Max Drawdown

Largest peak-to-trough decline

-30.23%

-24.51%

-5.72%

Max Drawdown (1Y)

Largest decline over 1 year

-9.93%

-13.73%

+3.80%

Max Drawdown (3Y)

Largest decline over 3 years

-23.09%

-24.51%

+1.42%

Max Drawdown (5Y)

Largest decline over 5 years

-30.23%

Current Drawdown

Current decline from peak

-5.41%

-10.88%

+5.47%

Average Drawdown

Average peak-to-trough decline

-10.57%

-7.69%

-2.88%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.45%

5.78%

-2.33%

Volatility

BIGT.L vs. HEAE.L - Volatility Comparison

L&G Pharma Breakthrough UCITS ETF (BIGT.L) has a higher volatility of 6.35% compared to SPDR MSCI Europe Health Care UCITS ETF (HEAE.L) at 5.60%. This indicates that BIGT.L's price experiences larger fluctuations and is considered to be riskier than HEAE.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BIGT.LHEAE.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.35%

5.60%

+0.75%

Volatility (6M)

Calculated over the trailing 6-month period

14.10%

12.12%

+1.98%

Volatility (1Y)

Calculated over the trailing 1-year period

18.38%

16.79%

+1.59%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.86%

16.28%

+0.58%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.38%

16.28%

+2.10%

BIGT.L vs. HEAE.L - Expense Ratio Comparison

BIGT.L has a 0.49% expense ratio, which is higher than HEAE.L's 0.18% expense ratio.


Dividends

BIGT.L vs. HEAE.L - Dividend Comparison

Neither BIGT.L nor HEAE.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


BIGT.L and HEAE.L have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, HEAE.L is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.

HEAE.L is cheaper with a 0.18% expense ratio, compared with 0.49% for BIGT.L.

BIGT.L tracks NASDAQ Biotechnology TR USD, while HEAE.L tracks MSCI World/Health Care NR USD. They also come from different issuers: Legal & General and State Street. Their fees differ too: 0.49% for BIGT.L and 0.18% for HEAE.L.

Portfolio Optimizer

Find the right allocation for BIGT.L and HEAE.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer